Embrex

Durham, United States Founded: 1985 • Age: 41 yrs Acquired By Pfizer
Biological and mechanical products for livestock are manufactured and supplied.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Embrex

Embrex is a company based in Durham (United States) founded in 1985 was acquired by Pfizer in January 2007. Embrex operates in a competitive market with competitors including Merck Animal Health, TARGAN, ViroVet, VitamFero and Intervacc, among others.

  • Headquarter Durham, United States
  • Sectors
    Agriculture
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Agriculture → Livestock & Animal Nutrition Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Pfizer

    (Jan 19, 2007)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Embrex

Premium access

Detailed funding history for Embrex

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Embrex

Embrex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pfizer.

All
Institutional
Investor Description Founded Year Domain Location
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Premium access

Investor details for Embrex

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Embrex

Investments
Premium access

Investment portfolio details for Embrex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Embrex

Premium access

Detailed financials for Embrex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Embrex Comparisons

Embrex Primary company
Description
Biological and mechanical products for livestock are manufac...
Location
Durham, United States
Founded Year
1985
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Embrex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Embrex

Embrex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, ViroVet, VitamFero and Intervacc, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Vaccine technology is developed and supplied for livestock animals.
Locked Locked Locked
Automated targeted vaccine systems for livestock and aquaculture are developed.
Locked Locked Locked
Manufacturer and supplier of antiviral drugs for livestock
Locked Locked Locked
Offers patented immunostimulating vaccines for livestock.
Locked Locked Locked
Recombinant vaccines for cattle, equine, and other livestock are developed.
Locked Locked Locked
Developer of vaccines and gene delivery platform
Premium access

Detailed competitors of Embrex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Embrex

Premium access

Complete news archive for Embrex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Embrex

Embrex was founded in 1985.

Embrex is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Embrex is a biotechnology company involved in the manufacturing and supply of biological and mechanical products for the livestock animals. It offers solutions for the breeders farmers such as Inovoject system (an automated in-the-egg injection system), egg remover system (to remove infertile and early dead eggs from incubator trays), vaccine saver (to identify infertile and early dead eggs and prevent vaccination of eggs). In addition, the company also offers consumables such as vaccines, parasiticides, anti-infectives, feed additives, etc.

Embrex's top competitors include TARGAN, Merck Animal Health and Intervacc.

Embrex has 1 investor. Key investors include Pfizer.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available